Observational case study reviews outcomes of carotid endarterectomy for carotid artery stenosis, suggesting improved stroke prevention.
At present, cerebral infarction has become a serious disease that endangers human health, and one of the important reasons for cerebral infarction is carotid artery stenosis. Carotid Endarterectomy (CEA) is a surgical procedure to treat carotid artery stenosis, its principle is to remove carotid plaque and relieve carotid artery stenosis, thereby increasing the distal cerebral blood supply and preventing cerebral infarction. Carotid endarterectomy was first performed on patients in 1953 by Professor De Bakey of vascular surgery and has been used for more than 70 years. Due to its effectiveness in the treatment of carotid artery stenosis, it has become an important routine operation in neurosurgery and cerebrovascular department, greatly reducing the risk of stroke in patients. In particular, a large number of clinical trials were represented by the North American Endarterectomy Trial for Symptomatic Carotid Stenosis (NASCET) [1], the European Carotid Surgery Trial (ECST) [2], the Asymptomatic Carotid Stenosis versus Aspirin Trial (CASANOVA) [3], and the Asymptomatic Carotid Surgery Trial (ACST) [4]. After the results of the bed trial were published successively, the effective role of CEA in the treatment of carotid atherosclerotic stenosis became more clearer, and the status of CEA was further consolidated. This paper reports a case of carotid endarterectomy and reviews the relevant literature.
No takes yet. Share an insight, caveat, or question.
Xiaodong Wang (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: